Abstract: Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Abstract: Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): wherein a group represented by is a group represented by the following formula (II) or the following formula (III): and other symbols are as described in the DESCRIPTION, or a salt thereof.

Abstract: A battery includes a casing, a terminal, an electrode assembly, a collector, and a joint. The terminal is supported by the casing. The electrode assembly is housed in the casing and includes an electrode pair of a sheet form having different polarities from each other and a separator located between the electrode pair, the electrode pair and the separator laminated and wound around an axis. The collector is located at an axial end of the electrode assembly, electrically connected to the terminal, and includes a plurality of collector tabs. The collector tabs are part of one of the electrodes and laminated on each other with no other electrode and the separator placed in-between. The joint joins fringes of the laminated collector tabs.

Abstract: According to one embodiment, a battery is provided. The battery includes an electrode body, a lead, a container member, and a terminal. The container member includes a main part and a terminal-connecting part adjacent to the main part. The electrode body is housed in the main part of the container member. The lead is electrically connected to the electrode body. The lead is housed in the terminal-connecting part of the container member. The terminal is electrically connected to the lead. The terminal is provided on the terminal-connecting part. A thickness of the main part of the container member is larger than a thickness of the terminal-connecting part of the container member.

Abstract: According to one embodiment, a battery is provided. The battery includes an electrode body, a lead, a container member, and a terminal. The container member includes a main part and a terminal-connecting part adjacent to the main part. The electrode body is housed in the main part of the container member. The lead is electrically connected to the electrode body. The lead is housed in the terminal-connecting part of the container member. The terminal is electrically connected to the lead. The terminal is provided on the terminal-connecting part. A thickness of the main part of the container member is larger than a thickness of the terminal-connecting part of the container member.

Abstract: The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Abstract: Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Abstract: According to one embodiment, a battery includes a flat-shaped electrode group, a package member and a terminal section. The package member includes a stainless steel-made first package having a flange at an opening and a stainless steel-made second package. The electrode group is stored in a space formed by welding the flange of the first package to the second package. The terminal section includes a through-hole that is open to the first package, a ring-shaped rising portion that extends from a periphery of the through-hole toward an inside of the package member, a ring-shaped member that is arranged on an outer surface of the rising portion, an insulation gasket, and an external terminal. The external terminal is fixed to the first package by caulking.

Abstract: Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): wherein a group represented by is a group represented by the following formula (II) or the following formula (III): and other symbols are as described in the DESCRIPTION, or a salt thereof.

Abstract: The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Abstract: The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Abstract: The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

Abstract: A battery disclosed herein includes a container member housing an electrode body and a lead, a gasket, an external terminal, and a restraining member. The container member includes a terminal-connecting part having a thickness of 0.3 mm or less. The terminal-connecting part includes a through hole including a rising part. The gasket includes a hollow shaft inserted into the rising part. The external terminal includes a terminal shaft. The terminal shaft includes a diameter-reduction part. The restraining member restrains at least a part of the diameter-reduction part of the terminal shaft via the diameter-reduction part of the rising part and the shaft of the gasket. The inclination angle of the rising part is larger than the inclination angle of the terminal shaft.

Abstract: According to one embodiment, a battery includes a flat-shaped electrode group, a package member and a terminal section. The package member includes a stainless steel-made first package having a flange at an opening and a stainless steel-made second package. The electrode group is stored in a space formed by welding the flange of the first package to the second package. The terminal section includes a through-hole that is open to the first package, a ring-shaped rising portion that extends from a periphery of the through-hole toward an inside of the package member, a ring-shaped member that is arranged on an outer surface of the rising portion, an insulation gasket, and an external terminal. The external terminal is fixed to the first package by caulking.

Abstract: According to one embodiment, a battery is provided. The battery includes an electrode body, a lead, a container member, and a terminal. The container member includes a main part and a terminal-connecting part adjacent to the main part. The electrode body is housed in the main part of the container member. The lead is electrically connected to the electrode body. The lead is housed in the terminal-connecting part of the container member. The terminal is electrically connected to the lead. The terminal is provided on the terminal-connecting part. A thickness of the main part of the container member is larger than a thickness of the terminal-connecting part of the container member.

Abstract: The present invention provides a fused heterocyclic compound that has CDK 8 and/or CDK 19 inhibitory activity. The present invention provides a compound represented by formula (I) (wherein the symbols are as defined in the description) or a salt thereof.

Abstract: The present invention provides a fused heterocyclic compound that has CDK 8 and/or CDK 19 inhibitory activity. The present invention provides a compound represented by formula (I) (wherein the symbols are as defined in the description) or a salt thereof.

Abstract: A battery disclosed herein includes a container member housing an electrode body and a lead, a gasket, an external terminal, and a restraining member. The container member includes a terminal-connecting part having a thickness of 0.3 mm or less. The terminal-connecting part includes a through hole including a rising part. The gasket includes a hollow shaft inserted into the rising part. The external terminal includes a terminal shaft. The terminal shaft includes a diameter-reduction part. The restraining member restrains at least a part of the diameter-reduction part of the terminal shaft via the diameter-reduction part of the rising part and the shaft of the gasket. The inclination angle of the rising part is larger than the inclination angle of the terminal shaft.

Abstract: A fuel cell has a fuel cell main body, a fuel supply unit, a voltage sensor, a supply speed determining unit, a fuel supply control unit, and a connecting unit. The voltage sensor measures the open-circuit voltage of the fuel cell main body. The supply speed determining unit determines the fuel supply speed of the fuel supply unit, on the basis of the results obtained from the measurement performed by the voltage sensor, in the case where the voltage measured by the voltage sensor is smaller than a predetermined value. The fuel supply control unit controls, on the basis of the supply speed thus determined, the fuel supply from the fuel supply unit. The connecting unit connects a load to the fuel cell main body, in the case where the voltage measured by the voltage sensor is larger than the predetermined value.

Abstract: A fuel cell has a fuel cell main body, a fuel supply unit, a voltage sensor, a supply speed determining unit, a fuel supply control unit, and a connecting unit. The voltage sensor measures the open-circuit voltage of the fuel cell main body. The supply speed determining unit determines the fuel supply speed of the fuel supply unit, on the basis of the results obtained from the measurement performed by the voltage sensor, in the case where the voltage measured by the voltage sensor is smaller than a predetermined value. The fuel supply control unit controls, on the basis of the supply speed thus determined, the fuel supply from the fuel supply unit. The connecting unit connects a load to the fuel cell main body, in the case where the voltage measured by the voltage sensor is larger than the predetermined value.